Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Allist licenses rights to two candidates from ProMetic

Executive Summary

ProMetic Life Sciences Inc. (cancer and hematology therapies) has granted Allist Pharmaceuticals Inc. (treatments for acid-related conditions, cardiovascular diseases, and cancer) exclusive rights to develop, manufacture, and sell two candidates--PBI1402 and PBI4419--in China.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register